Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Pelletier

Showing results (71-80 of 194) with videos related to

Pageof 20
Sort By:
Journal of Neuroradiology = Journal De Neuroradiologie|November 21, 2016
Hypoperfusion of the thalamus is associated with disability in relapsing remitting multiple sclerosisEmilie Doche, Angèle Lecocq, Adil Maarouf, et al.
Clinical Neurology and Neurosurgery|April 6, 2020
Effect of hyperglycemia on stroke outcome is not homogeneous to all patients treated with mechanical thrombectomyLaurent Suissa, Emilie Panicucci, Charline Perot, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 27, 2015
Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS studyJeffrey A Cohen, Bhupendra Khatri, Frederik Barkhof, et al.
Journal of the Neurological Sciences|November 8, 2017
Improvement of quality of life and its relationship with neuropsychiatric outcomes in patients with multiple sclerosis starting treatment with natalizumab: A 3-year follow-up multicentric studyVincent Planche, Xavier Moisset, Remy Morello, et al.
Imaging Neuroscience (Cambridge, Mass.)|August 13, 2025
Inhomogeneous magnetization transfer (ihMT) imaging reveals variable recovery profiles of active MS lesions according to size and localizationLucas Soustelle, Samira Mchinda, Andreea Hertanu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2022
Grey-matter sodium concentration as an individual marker of multiple sclerosis severityAdil Maarouf, Bertrand Audoin, Soraya Gherib, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2021
Post-vaccine COVID-19 in patients with multiple sclerosis or neuromyelitis opticaEdouard Januel, Jérôme De Seze, Patrick Vermersch, et al.
Magnetic Resonance in Medicine|September 24, 2017
Whole brain inhomogeneous magnetization transfer (ihMT) imaging: Sensitivity enhancement within a steady-state gradient echo sequenceSamira Mchinda, Gopal Varma, Valentin H Prevost, et al.
Plos One|September 28, 2011
Prevalence of grey matter pathology in early multiple sclerosis assessed by magnetization transfer ratio imagingLydie Crespy, Wafaa Zaaraoui, Mathias Lemaire, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 20, 2021
Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapyAudrey Rico, Laetitia Ninove, Adil Maarouf, et al.
Pageof 20

Showing results (71-80 of 194) with videos related to

Sort By:
Pageof 20
Journal of Neuroradiology = Journal De Neuroradiologie|November 21, 2016
Hypoperfusion of the thalamus is associated with disability in relapsing remitting multiple sclerosisEmilie Doche, Angèle Lecocq, Adil Maarouf, et al.
Clinical Neurology and Neurosurgery|April 6, 2020
Effect of hyperglycemia on stroke outcome is not homogeneous to all patients treated with mechanical thrombectomyLaurent Suissa, Emilie Panicucci, Charline Perot, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 27, 2015
Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS studyJeffrey A Cohen, Bhupendra Khatri, Frederik Barkhof, et al.
Journal of the Neurological Sciences|November 8, 2017
Improvement of quality of life and its relationship with neuropsychiatric outcomes in patients with multiple sclerosis starting treatment with natalizumab: A 3-year follow-up multicentric studyVincent Planche, Xavier Moisset, Remy Morello, et al.
Imaging Neuroscience (Cambridge, Mass.)|August 13, 2025
Inhomogeneous magnetization transfer (ihMT) imaging reveals variable recovery profiles of active MS lesions according to size and localizationLucas Soustelle, Samira Mchinda, Andreea Hertanu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2022
Grey-matter sodium concentration as an individual marker of multiple sclerosis severityAdil Maarouf, Bertrand Audoin, Soraya Gherib, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2021
Post-vaccine COVID-19 in patients with multiple sclerosis or neuromyelitis opticaEdouard Januel, Jérôme De Seze, Patrick Vermersch, et al.
Magnetic Resonance in Medicine|September 24, 2017
Whole brain inhomogeneous magnetization transfer (ihMT) imaging: Sensitivity enhancement within a steady-state gradient echo sequenceSamira Mchinda, Gopal Varma, Valentin H Prevost, et al.
Plos One|September 28, 2011
Prevalence of grey matter pathology in early multiple sclerosis assessed by magnetization transfer ratio imagingLydie Crespy, Wafaa Zaaraoui, Mathias Lemaire, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 20, 2021
Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapyAudrey Rico, Laetitia Ninove, Adil Maarouf, et al.
Pageof 20